Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Jul;19(7):939-41.
doi: 10.1007/s00464-004-8929-3. Epub 2005 May 5.

Postoperative complications are not increased in super-super obese patients who undergo laparoscopic Roux-en-Y gastric bypass

D S Tichansky  1 , E J DeMaria, A Z Fernandez, J M Kellum, L G Wolfe, J G Meador, H J Sugerman
Affiliations

Postoperative complications are not increased in super-super obese patients who undergo laparoscopic Roux-en-Y gastric bypass

D S Tichansky et al. Surg Endosc. 2005 Jul.

Abstract

Background: It has been suggested that super-super obesity (body mass index [BMI] > or =60 kg/m2) increases the risk of complications after laparoscopic Roux-en-Y gastric bypass (LapRYGB). We hypothesized that a higher BMI does not increase risk the morbidity or mortality rate.

Methods: Complication rates for patients with a BMI > or =60 kg/m2 were compared to those for patients with a BMI <60 kg/m2 who underwent LapRYGB during the same time period. Differences between the groups were analyzed by Fisher's exact test, t-tests, and analysis of variance.

Results: Forty-five patients with a BMI > or =60 kg/m2 and 640 patients with a BMI <60 kg/m2 underwent LapRYGB. There were no statistically significant differences between the two groups in the complication or mortality rates. Excess weight loss was less, but actual weight lost was greater in the BMI > or =60 kg/m2 group.

Conclusions: The complication and mortality rates are not increased in super-super obese patients who undergo LapRYGB. Acceptable weight loss can be achieved safely in these patients.

PubMed Disclaimer

References

    1. Obes Surg. 2004 Jan;14(1):91-4 - PubMed
    1. Obes Surg. 2002 Oct;12(5):643-7 - PubMed
    1. Surgery. 1989 Mar;105(3):337-46 - PubMed
    1. Surg Endosc. 2003 Feb;17(2):212-5 - PubMed
    1. JAMA. 2004 Mar 10;291(10):1238-45 - PubMed